Publications
Publications From: Kalon K.L. Ho, MD, MSc
Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial. Circulation. 2004 Jun 8;109(22):2727-31.
Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation. 2004 Sep 7;110(10):1226-30.
Effects of stent length and lesion length on coronary restenosis. Am J Cardiol. 2004 Jun 1;93(11):1340-6, A5.
Economic assessment of rheolytic thrombectomy versus intracoronary urokinase for treatment of extensive intracoronary thrombus: Results from a randomized clinical trial. Am Heart J. 2001 Oct;142(4):648-56.
Coronary artery stenting in the aged. J Am Coll Cardiol. 2001 Mar 1;37(3):856-62.
Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol. 2001 Jan 15;87(2):152-6.
Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial. Am J Cardiol. 2002 Nov 15;90(10):1079-83.
Impact of smoking on health-related quality of life after percutaneous coronary revascularization. Circulation. 2000 Sep 19;102(12):1369-74.
Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol. 2001 Jan 15;87(2):157-62.
Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007 Mar 8;356(10):1020-9.
Kalon K.L. Ho MD, MSc, Joseph Massaro PhD, Laura Mauri MD, Ralph D'Agostino PhD, and Donald E. Cutlip MD
